IRCT138811212779N2.
Methods | Parallel RCT (double blind) |
Participants | HD patients |
Interventions | L‐carnitine (IV): 1000 mg at each dialysis session/ubiquinone (oral) 100 mg/day |
Outcomes | Cardiovascular risk factors |
Notes | Protocol registration only; current status is unknown |